Likewise, in human CRC cells (SW480), ERK1/2 phosphorylation was confined within the cytoplasm, while treatment with pervanadate, a tyrosine phosphatase inhibitor effective on DUSP, was necessary to activate ERK1/2 in the nucleus. The gene discussed is MAPK3; the disease is colorectal carcinoma.